...
cdna-img

Caredx Inc, Common Stock

CDNA

NMQ

$14.83

+$3.77

(34.09%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$767.88M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
NM
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.49M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
853.61K
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.51
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4.8 L
$12.93 H
$14.83

About Caredx Inc, Common Stock

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCDNASectorS&P500
1-Week Return52.57%1.96%1.74%
1-Month Return60.15%1.41%1.16%
3-Month Return63.51%-0.06%4.18%
6-Month Return100.13%14.64%18.97%
1-Year Return72.64%9.92%28.01%
3-Year Return-77.75%21.12%30.32%
5-Year Return-54.04%76.06%96.32%
10-Year Return63.87%188.86%230.23%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue127.07M192.19M296.40M321.79M280.32M[{"date":"2019-12-31","value":39.49,"profit":true},{"date":"2020-12-31","value":59.73,"profit":true},{"date":"2021-12-31","value":92.11,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":87.11,"profit":true}]
Cost of Revenue45.45M63.12M97.39M112.21M104.46M[{"date":"2019-12-31","value":40.51,"profit":true},{"date":"2020-12-31","value":56.25,"profit":true},{"date":"2021-12-31","value":86.79,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.09,"profit":true}]
Gross Profit81.61M129.08M199.01M209.58M175.87M[{"date":"2019-12-31","value":38.94,"profit":true},{"date":"2020-12-31","value":61.59,"profit":true},{"date":"2021-12-31","value":94.96,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.91,"profit":true}]
Gross Margin64.23%67.16%67.14%65.13%62.74%[{"date":"2019-12-31","value":95.63,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":99.97,"profit":true},{"date":"2022-12-31","value":96.98,"profit":true},{"date":"2023-12-31","value":93.42,"profit":true}]
Operating Expenses106.14M146.79M228.73M286.81M277.77M[{"date":"2019-12-31","value":37.01,"profit":true},{"date":"2020-12-31","value":51.18,"profit":true},{"date":"2021-12-31","value":79.75,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.85,"profit":true}]
Operating Income(24.53M)(17.71M)(29.73M)(77.23M)(101.90M)[{"date":"2019-12-31","value":-2453200000,"profit":false},{"date":"2020-12-31","value":-1771500000,"profit":false},{"date":"2021-12-31","value":-2972600000,"profit":false},{"date":"2022-12-31","value":-7723100000,"profit":false},{"date":"2023-12-31","value":-10190000000,"profit":false}]
Total Non-Operating Income/Expense1.57M(1.76M)(2.20M)4.76M(76.38M)[{"date":"2019-12-31","value":32.99,"profit":true},{"date":"2020-12-31","value":-37.07,"profit":false},{"date":"2021-12-31","value":-46.27,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1604.87,"profit":false}]
Pre-Tax Income(23.95M)(19.75M)(32.09M)(76.23M)(190.14M)[{"date":"2019-12-31","value":-2394700000,"profit":false},{"date":"2020-12-31","value":-1975000000,"profit":false},{"date":"2021-12-31","value":-3208800000,"profit":false},{"date":"2022-12-31","value":-7623400000,"profit":false},{"date":"2023-12-31","value":-19014300000,"profit":false}]
Income Taxes(1.98M)(1.04M)(1.43M)379.00K141.00K[{"date":"2019-12-31","value":-522.16,"profit":false},{"date":"2020-12-31","value":-273.35,"profit":false},{"date":"2021-12-31","value":-376.25,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":37.2,"profit":true}]
Income After Taxes(21.97M)(18.71M)(30.66M)(76.61M)(190.28M)[{"date":"2019-12-31","value":-2196800000,"profit":false},{"date":"2020-12-31","value":-1871400000,"profit":false},{"date":"2021-12-31","value":-3066200000,"profit":false},{"date":"2022-12-31","value":-7661300000,"profit":false},{"date":"2023-12-31","value":-19028400000,"profit":false}]
Income From Continuous Operations(21.97M)(18.71M)(30.66M)(76.61M)(190.28M)[{"date":"2019-12-31","value":-2196800000,"profit":false},{"date":"2020-12-31","value":-1871400000,"profit":false},{"date":"2021-12-31","value":-3066200000,"profit":false},{"date":"2022-12-31","value":-7661300000,"profit":false},{"date":"2023-12-31","value":-19028400000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(21.97M)(18.71M)(30.66M)(76.61M)(190.28M)[{"date":"2019-12-31","value":-2196800000,"profit":false},{"date":"2020-12-31","value":-1871400000,"profit":false},{"date":"2021-12-31","value":-3066200000,"profit":false},{"date":"2022-12-31","value":-7661300000,"profit":false},{"date":"2023-12-31","value":-19028400000,"profit":false}]
EPS (Diluted)(0.08)0.080.29(0.39)(0.64)[{"date":"2019-12-31","value":-27.59,"profit":false},{"date":"2020-12-31","value":27.59,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-134.48,"profit":false},{"date":"2023-12-31","value":-220.69,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CDNA
Cash Ratio 3.02
Current Ratio 4.02
Quick Ratio 3.77

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CDNA
ROA (LTM) -12.88%
ROE (LTM) -54.98%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CDNA
Debt Ratio Lower is generally better. Negative is bad. 0.46
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.54
Debt/Equity The higher the number, the more leverage the business employs, the riskier the investment typically is. 1.79

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CDNA
Trailing PE NM
Forward PE NM
P/S (TTM) 1.58
P/B 1.69
Price/FCF NM
EV/R 0.85
EV/Ebitda NM
PEG 0.02

News

CDNA Stock Earnings: CareDx Beats EPS, Beats Revenue for Q1 2024

CareDx (NASDAQ: CDNA ) just reported results for the first quarter of 2024. CareDx reported earnings per share of -3 cents. This was above the analyst estimate for EPS of -19 cents. The company reported revenue of $72.05 million. This was 13.46% better than the analyst estimate for revenue of $63.50 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. It doesn’t matter if you have $500 or $5 million.

10 May, 2024 a 1:55 am InvestorPlace

CareDx: Q1 Earnings Snapshot

BRISBANE, Calif. (AP) — BRISBANE, Calif. (AP) — CareDx Inc. (CDNA) on Thursday reported a loss of $16.7 million in…

9 May, 2024 a 9:32 pm WTOP

FAQs

What is Caredx Inc share price today?

Caredx Inc (CDNA) share price today is $14.83

Can Indians buy Caredx Inc shares?

Yes, Indians can buy shares of Caredx Inc (CDNA) on Vested. To buy Caredx Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CDNA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Caredx Inc be purchased?

Yes, you can purchase fractional shares of Caredx Inc (CDNA) via the Vested app. You can start investing in Caredx Inc (CDNA) with a minimum investment of $1.

How to invest in Caredx Inc shares from India?

You can invest in shares of Caredx Inc (CDNA) via Vested in three simple steps:

  • Click on Sign Up or Invest in CDNA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Caredx Inc shares
What is Caredx Inc 52-week high and low stock price?

The 52-week high price of Caredx Inc (CDNA) is $12.93. The 52-week low price of Caredx Inc (CDNA) is $4.8.

What is Caredx Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Caredx Inc (CDNA) is NM

What is Caredx Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Caredx Inc (CDNA) is 1.69

What is Caredx Inc dividend yield?

The dividend yield of Caredx Inc (CDNA) is 0.00%

What is the Market Cap of Caredx Inc?

The market capitalization of Caredx Inc (CDNA) is $767.88M

What is Caredx Inc’s stock symbol?

The stock symbol (or ticker) of Caredx Inc is CDNA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top